Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities

102Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Infants with aortic arch interruption or juxtaductal coarctation of the aorta may depend on patency of the ductus arteriosus to provide adequate lower body perfusion. In many such infants the ductus arteriosus constricts after birth, resulting in severe heart failure, poor perfusion and acidemia. We infused prostaglandin E1 (PGE1) at a rate of 0.05-0.1 μg/kg/min into seven infants with aortic arch interruption and eight infants with coarctation. In one infant in each group the ductus arteriosus was already closed and did not reopen. In one infant with coarctation an adequate trial was not accomplished, and in another adequate pressure measurements were not obained. Of the remaining 11, the ductus arteriosus was effectively dilated by PGE1 in 10 infants. This was evidenced by an increase in descending aortic blood pressure and a reduction in the pressure difference between the main pulmonary artery and descending aorta in six infants with aortic arch interruption and between ascending and descending aorta in four infants with coarctation. Lower body perfusion improved and left ventricular failure was improved. The infant who did not respond was 5 months old. There were no complications.

Cite

CITATION STYLE

APA

Heymann, M. A., Berman, W., Rudolph, A. M., & Whitman, V. (1979). Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities. Circulation, 59(1), 169–173. https://doi.org/10.1161/01.CIR.59.1.169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free